Iranian Journal of Public Health 2017. 46(10):1324-1331.

The Incidence and Mortality of Cervical Cancer in Ningbo during 2006-2014, China
Hui LI, Donghui DUAN, Jiaying XU, Qinghai GONG, Yong WANG, Wei JI, Lingbin DU, Liyuan HAN, Guozhang XU

Abstract


Background: The purpose of this study was to investigate the incidence and mortality rates of cervical cancer during 2006-2014 in Ningbo, China.

Methods: A retrospective study involved 3418 newly diagnosed cervical cancer cases and 854 death cases were performed. All cases were registered in Cancer Registry Center of Ningbo Centers for Disease Control and Prevention. Results were expressed as standardized age-specific cancer incidence/mortality rates with confidence intervals. All P-values presented were two-sided and the statistical significance was set at P<0.05.

Results: The crude incidence rate was 34.35 per 100000 in females aged 50-54 years. Females aged 80-84 years had the highest crude mortality rates, which were 12.91 per 100000. The average age-standardized incidence and mortality rates by Chinese Standard Population were 6.29 and 1.49 per 100000, respectively. The average age-standardized incidence and mortality rates by World Standard Population were 8.02 and 1.91 per 100000, respectively. The incidence trend graph showed that annual percent change (APC) increased rapidly by 30.2% (P<0.01) during 2006-2014, while the mortality trend graph indicated a rapid increase in mortality annually by 8.8% (P<0.01) during 2006-2014.

Conclusion: We observed an increased trend for both incidence and mortality rates of cervical cancer in Ningbo during 2006 to 2014, which indicated the urgent need for free regular screening for high-risk populations by the government.

 


Keywords


Cervical cancer, Incidence, Mortality, China

Full Text:

PDF

References


Jemal A, Bray F, Center MM et al (2011). Global cancer statistics. CA Cancer J Clin, 61(2): 69-90.

Zhang SK, Kang LN, Chang IJ et al (2014). The natural history of cervical cancer in chinese women: results from an 11-year follow-up study in china using a multistate model. Cancer Epidemiol Biomarkers Prev, 23(7): 1298-305.

Cannistra SA, Niloff JM (1996). Cancer of the uterine cervix. N Engl J Med, 334: 1030-1037.

Simard EP, Naishadham D, Saslow D, Jemal A (2012). Age-specific trends in black-white disparities in cervical cancer incidence in the United States: 1975-2009. Gynecol Oncol, 127(3): 611-5.

Chen W, Zheng R, Baade PD et al (2016). Cancer statistics in China, 2015. CA Cancer J Clin, 66(2): 115-32.

Yang L, Huangpu XM, Zhang SW et al (2003). Changes of mortality rate for cervical cancer during 1970's and 1990's periods in China. Zhong Guo Yi Xue Ke Xue Yuan Xue Bao, 25(4): 386-90.

Shi JF, Canfell K, Lew JB, Qiao YL (2012). The burden of cervical cancer in China: synthesis of the evidence. Int J Cancer, 130(3): 641-52.

Wang T, Wu MH, Wu YM, Zhang WY (2015). A Population-based Study of Invasive Cervical Cancer Patients in Beijing: 1993-2008. Chin Med J (Engl), 128(24): 3298-3304.

Zeng HM, Zheng RS, Zhang SW et al (2012). Trend analysis of cancer mortality in China between 1989 and 2008. Zhonghua Zhong Liu Za Zhi, 34(7): 525-31.

World Health Organization (2014). Comprehensive cervical cancer control: A guide to essential practice. http://apps.who.int/iris/bitstream/10665/144785/1/9789241548953_eng.pdf

Di J, Rutherford S, Chu C (2015). Review of the Cervical Cancer Burden and Population-Based Cervical Cancer Screening in China. Asian Pac J Cancer Prev, 16(17):7401-7.

Hu SY, Zheng RS, Zhao FH et al (2014). [Trend analysis of cervical cancer incidence and mortality rates in Chinese women during 1989-2008]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 36(2): 119-25.

Zhou Y, Du J, Pan L, Li H, Du L (2014). Analysis of cervical cancer incidence and mortality in cancer registries of Zhejiang province, 2000 to 2009. Zhonghua Yu Fang Yi Xue Za Zhi, 48(8): 674-7.

National Bureau of Statistics of China (2015). China Statistical Yearbook 2015. China statistics press. http://www.stats.gov.cn/tjsj/ndsj/2015/indexeh.htm

Ningbo Municipal Government (2014). Summary statistics of industry and economy of Ningbo, 2015 [in Chinese]. http://www.nbstats.gov.cn/

Li SJ, Xu GZ, Ji W et al (2012). Epidemiology of cervical cancer in Ningbo, Zhejiang, 2006-2010. Disease Surveillance, 27(3): 218-220.

Chen W, Zheng R, Zeng H, Zhang S, He J (2015). Annual report on status of cancer in China, 2011. Chin J Cancer Res, 27(1): 2-12.

Li S, Hu T, Lv W et al (2013). Changes in prevalence and clinical characteristics of cervical cancer in the People's Republic of China: a study of 10,012 cases from a nationwide working group. Oncologist, 18(10): 1101-7.

Zhao P, Chen WQ, Kong LZ (2000). Cancer Incidence and Mortality in China (2003-2007). Military Medical Science Press.

Lin L, Qiu JX (2012). Ningbo Area Prevention and Control of Environmental Pollution. Energy And Energy Conservation, 7: 59-71.

Gonzaga CM, Freitas-Junior R, Barbaresco AA et al (2013). Cervical cancer mortality trends in Brazil: 1980-2009. Cad Saude Publica, 29(3): 599-608.

Walboomers JM, Jacobs MV, Manos MM et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189(1): 12-9.

Scheurer ME, Tortolero-Luna G, Adler-Storthz K (2005). Human papillomavirus infection: biology, epidemiology, and prevention. Int J Gynecol Cancer, 15(5): 727-46.

Wheeler, CM (2008). Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer. Obstet Gynecol Clin North Am, 35(4): 519-36.

Du PL, Wu KS, Fang JY et al (2015). Cervical Cancer Mortality Trends in China, 1991-2013, and Predictions for the Future. Asian Pac J Cancer Prev, 16(15): 6391-6.

Johnson DC, Bhatta MP, Gurung S et al (2014). Knowledge and Awareness of Human Papillomavirus (HPV), Cervical Cancer and HPV Vaccine among Women in Two Distinct Nepali Communities. Asian Pac J Cancer Prev, 15(19): 8287-93.

Bryan JT, Buckland B, Hammond J, Jansen KU (2016). Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine. Curr Opin Chem Biol, 32: 34-47.

Murthy NS, Chaudhry K, Saxena, S (2005). Trends in cervical cancer incidence--Indian scenario. Eur J Cancer Prev, 14(6): 513-8.

Ioka A, Ito Y, Tsukuma H (2009). Factors relating to poor survival rates of aged cervical cancer patients: a population-based study with the relative survival model in Osaka, Japan. Asian Pac J Cancer Prev, 10(3): 457-62.

Boo YK, Kim WC, Lee HY et al (2011). Incidence trends in invasive uterine cervix cancer and carcinoma in situ in Incheon, South Korea. Asian Pac J Cancer Prev, 12(8): 1985-8.

Jung KW, Won YJ, Kong HJ et al (2014). Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat, 46(2): 109-123.

Zhang CY, Zhong HZ, Jiang Y et al (2013). Survey on preventive methods availability for cervical cancer in medical institutions and cognition on cancer screening among women in Ningbo. Zhong Guo Yu Fang Yi Xue Za Zhi, 6(14): 439-443.

Li J, Kang LN,Qiao YL (2011). Review of the cervical cancer disease burden in mainland China. Asian Pac J Cancer Prev, 12(5): 1149-53.

Watson M, Benard V, Thoma C et al (2014). Cervical cancer incidence and mortality among American Indian and Alaska Native women, 1999-2009. Am J Public Health, 104 Suppl 3:S415-22.

Anttila A, Ronco G, Clifford G et al (2004). Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer, 91(5): 935-41.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.